Abrahmsen Lars B.
- SEC CIK
- 0001789039
No open-market purchases or sales filed in the past year.
Current role at each company
- APRE Aprea Therapeutics, Inc.SVP, Chief Scientific Officeras of Mar 14, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Abrahmsen Lars B. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 5, 2021 (view filing) | Oct 1 | 4 days | Abrahmsen Lars B.SVP, Chief Scientific Officer | SSale | −50.0K | $4.89 | −$244.5K | −72.5%19.0K after | |
| Sep 22, 2021 (view filing) | Sep 20 | 2 days | Abrahmsen Lars B.SVP, Chief Scientific Officer | SSale | −25.0K | $4.97 | −$124.3K | −56.8%19.0K after |